Medtronic plc (ETR:2M6)

Market Cap	111.10B +4.4%
Revenue (ttm)	29.88B +5.3%
Net Income	4.10B +11.1%
EPS	3.17 +13.0%
Shares Out	n/a
PE Ratio	27.13
Forward PE	17.55
Dividend	2.47 (2.84%)
Ex-Dividend Date	Dec 26, 2025

Volume	1,004
Average Volume	1,615
Open	86.60
Previous Close	85.43
Day's Range	86.30 - 87.03
52-Week Range	70.58 - 91.50
Beta	0.73
RSI	53.43
Earnings Date	Feb 17, 2026

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 2M6

Financial Performance

In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD